The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.
October 19, 1987|
One of the most highly motivated scientists I have observed over the years has devoted much of his career to testing athletes for illicit drugs. He is an energetic man, a resourceful technician and a person clearly inspired by the goal of achieving total fairness in the gladiatorial arena. He argues forcefully for the proposition that international sporting competitions (indeed, any sporting competition) should be free of artificial chemical crutches. His ideal is the Olympic ideal—the n